Analytical Data
-
Gene name
MPIF1
- Application
-
Alternative Names
MPIF1；MIP3；MPIF1；SCYA23；C-C motif chemokine 23
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P55773
-
Expression Region
22-120aa
-
AA Sequence
RVTKDAETEF MMSKLPLENP VLLDRFHATS ADCCISYTPR SIPCSLLESY FETNSECSKP GVIFLTKKGR RFCANPSDKQ VQVCMRMLKL DTRIKTRKN
-
Molecular Weight
11.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MPIF1, or Myeloid Progenitor Inhibitory Factor 1, is a cytokine primarily involved in hematopoiesis and immune regulation. It was first identified for its role in inhibiting the proliferation of myeloid progenitor cells, which are precursors to various blood cell types. Research surrounding MPIF1 has shifted focus towards its broader implications in immunological processes and potential therapeutic applications. Given its involvement in modulating immune responses, MPIF1 is of interest in contexts such as inflammatory diseases, autoimmune disorders, and cancer. The recombinant form of MPIF1 has been produced to better understand its biological functions and mechanisms of action. This research aims to elucidate the pathways influenced by MPIF1, providing insights into its potential as a drug target. The advancement of recombinant protein technologies has enabled the production of high-purity MPIF1, facilitating detailed studies on its structure, function, and interactions with other molecules within the immune system. Understanding MPIF1's role could pave the way for innovative treatments that harness the immune system's power, highlighting the importance of ongoing investigations into this cytokine in both basic and applied biomedical research.
